The Stanford Headache Program Clinical Trials

Sunstar: The Stanford Neuroscience Headache Biorepository (NCT03231241)
PI: Robert P. Cowan, MD, FAAN, FAHS
Status: Active, Enrolling

Research Coordinator: Bharati Sanjanwala
Contact: bharatis@stanford.edu

Diagnostic comparison of an online questionnaire versus a semi-structured interview for the diagnosis of primary headache disorders, using ICHD 3 as the Gold Standard (NCT03304886)
PI: Robert P. Cowan, MD, FAAN, FAHS
Status: Active, Enrolling

Research Coordinator: Bharati Sanjanwala
Contact: bharatis@stanford.edu

A Multicenter, Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group Study Comparing the Efficacy and Safety of 2 Dose Regimens (Intravenous/Subcutaneous and Subcutaneous) of TEV-48125 Versus Placebo for the Prevention of Episodic Cluster Headache (NCT02945046)
Study Status: Active, Enrolling
PI:
Nada Hindiyeh, MD
Research Coordinator: Jake Hartley
Contact: jakemh@stanford.edu

A Multicenter, Double-Blind, Double-Dummy Study to Explore the Long-Term Safety of TEV-48125 for the Prevention of Cluster Headache (NCT03107052)
Study Status:
Active, Enrolling
PI: Nada Hindiyeh, MD

Research Coordinator: Jake Hartley
Contact: jakemh@stanford.edu

A Phase 3b Multicenter, Single-arm, Open-label Safety Study of Ly2951742 (Galcanezumab) in Patients with Episodic or Chronic Cluster Headache (NCT02797951)
Study Status: Active, Enrolling
PI: Nada Hindiyeh, MD

Research Coordinator: Jake Hartley
Contact: jakemh@stanford.edu

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 with a Long-Term Open-Label Extension in Patients with Chronic Cluster Headache (NCT02438826)
Status: Active, Enrolling
PI: Nada Hindiyeh, MD

Research Coordinator: Jake Hartley
Contact: jakemh@stanford.edu

Sphenopalatine Ganglion Stimulation for the Treatment of Chronic Cluster Headache (NCT02168764)
Status: Active, Closed to Enrollment
PI: Nada Hindiyeh, MD

A Long-Term, Open-Label Safety Study to Evaluate the Safety of M207 (Intracutaneous Microneedle System) in the Acute Treatment of Migraine (NCT03282227)
Status: Active, Closed to Enrollment
PI: Nada Hindiyeh, MD

A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients with Episodic Cluster Headache (NCT02397473)
Status: Active, Closed to Enrollment
PI: Nada Hindiyeh, MD

For more information on our clinical trials

Maria Coburn
Clinical Research Manager
mcoburn@stanford.edu

(650) 736-9551